NCT07259317 2026-02-20Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaCorcept TherapeuticsPhase 2 Recruiting60 enrolled
NCT06906341 2025-10-22Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersCorcept TherapeuticsPhase 2 Recruiting270 enrolled